Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrafast, Low-Cost Point-of-Care PCR Testing System Provides Central Lab Precision in 15 Minutes

By LabMedica International staff writers
Posted on 16 May 2023

Despite the rapid progress in medical testing, there's still a pressing demand for improved diagnostic and screening tools for infectious bacterial and viral pathogens. More...

Currently, nucleic acid amplification tests (NAAT), such as RT-PCR, are the “gold standard” for accuracy, with the highest analytic sensitivity. However, PCR testing requires specialized lab equipment, significant technical knowledge, and is costly, time-intensive, and often inaccessible in remote or under-resourced areas. Now, a compact, portable platform that can be operated by non-technical personnel takes testing out of the traditional laboratory environment by consolidating the entire PCR testing process (sample extraction and PCR), providing results in approximately 15 minutes.

The DASH (Diagnostic Analyzer for Specific Hybridization) quantitative PCR system from Minute Molecular Diagnostics (Evanston, IL, USA) is roughly the size of a cereal box, making it compact enough to fit on a countertop or desk. DASH delivers the same accuracy as other PCR tests in a compact portable platform that can be utilized by non-technical personnel at the point of care. It identifies infectious bacterial and viral pathogens in under 15 minutes, requiring less than a minute of hands-on time. During the initial 10 minutes, samples are extracted and purified with sequence-specific capture probes. Paramagnetic particles (PMP) are introduced to bind to the target probe complex. Subsequently, the targets are magnetically separated from the swab extraction buffer, cleaned, and moved to the PCR chamber. During the final five minutes of the assay, 40 PCR temperature cycles are executed, with fluorescence measured via a four-channel optical system.

DASH's defining features are its user-friendly nature, quickness, and PCR-level precision. The DASH interface guides users through each step, making it as simple to operate as a coffee machine. Although initially conceived to combat the COVID-19 pandemic, the technology is versatile, capable of detecting a range of viral and bacterial pathogens. Presently, Minute Molecular Diagnostics is working on developing similar tests for influenza, HIV, Hepatitis C, several sexually transmitted diseases, MRSA, and C. diff, compatible with various sample types, including nasal swabs, saliva, and blood. The DASH PCR testing system can also provide a quantitative report of HIV and Hepatitis C viral loads. Its compact size facilitates testing in hospital and non-hospital settings. DASH units can be linked together to deliver between 4 and 24 test results per hour, making it an excellent choice for point-of-care testing in clinics, businesses, or community environments.

Related Links:
Minute Molecular Diagnostics 


New
Gold Member
Hybrid Pipette
SWITCH
Collection and Transport System
PurSafe Plus®
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LungCanSeek demonstrated an overall sensitivity of 83.5% and specificity of 90.3% in detecting lung cancer (Photo courtesy of AdobeStock)

New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

Lung cancer remains the leading cause of cancer-related deaths worldwide, largely because most cases are diagnosed at advanced stages when treatment options are limited. Early detection significantly improves... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The TriVerity IVD test includes the TriVerity cartridge and the Myrna instrument (Photo courtesy of Inflammatix)

Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients

When a patient enters the emergency department in critical condition, clinicians must rapidly decide whether the patient has an infection, whether it is bacterial or viral, and whether immediate treatment... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.